A Randomized Phase II Study of Stereotactic Ablative Body Radiotherapy for Metastases to the Lung (TROG 13.01 SAFRON II)
Clinical trial NCT01965223 · COMPLETED
Trial details
- NCT number
- NCT01965223
- Sponsor
- Trans Tasman Radiation Oncology Group
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-04
- Primary completion
- 2020-07-27
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.